Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

PSID, Turning The Corner?

Summary

Developing FireflyDX products that are portable, all-in-one lab MDx solutions that accurately detect pathogens in 30 minutes using real-time PCR, without additional equipment or additional confirmatory testing.

FireflyDX leverages $35M of investment from U.S. Department of Homeland Security for the development of the predecessor/foundation technology.

PSID markets the FDA-cleared Caregiver® thermometer, a clinical-grade, infrared thermometer that measures forehead temperature in adults, children, and infants, without contact.

PSID Announced Today That E-N-G Mobile Systems Has Received A 1 Million Dollar Purchase Order For A Highly Technical Vehicle. PSID Owns 24% Of E-N-G. PSID Have Two Additional Businesses With Innovative, Disruptive Products Positioned To Revolutionize Biological Testing, Detection And Diagnostics. They Currently Hold 22 Patents And Are Well Positioned In The Global Molecular Diagnostics Market Estimated At $45B By 2020; Global PCR Market Estimated At $13B By 2020; Food Safety Testing Projected To Reach $19B By 2018.

Disclosure: I am/we are long PSID-OLD.